v3.23.2
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
May 31, 2023
May 31, 2022
Consolidated Statements of Operations    
Revenue $ 0 $ 266
Cost of goods sold   53
Gross profit   213
Operating expenses:    
General and administrative 17,136 44,303
Research and development 2,632 27,043
Amortization and depreciation 175 781
Inventory charge 20,633 73,490
Total operating expenses 40,576 145,617
Operating loss (40,576) (145,404)
Interest and other expenses:    
Interest on convertible notes (4,624) (5,417)
Amortization of discount on convertible notes (2,126) (2,958)
Amortization of debt issuance costs (9,747) (87)
Loss on induced conversion (5,312) (37,381)
Finance charges (8,689) (9,029)
Inducement interest expense   (6,691)
Legal settlement   (3,853)
Loss on derivatives (8,750)  
Total interest and other expenses (39,248) (65,416)
Loss before income taxes (79,824) (210,820)
Income tax benefit 0 0
Net loss $ (79,824) $ (210,820)
Weighted average common shares outstanding, Basic 836,528 676,900
Weighted average common shares outstanding, Diluted 836,528 676,900
Loss per share, Basic $ (0.10) $ (0.31)
Loss per share, Diluted $ (0.10) $ (0.31)

Source